Introduction {#S1}
============

Vitamin D, a secosteroid, is synthesized in skin and then metabolized in kidneys and liver of humans. It plays an important role in maintaining phosphorus and calcium homeostasis and accelerating bone mineralization. Emerging evidence shows that vitamin D deficiency is associated with high risk of cardiovascular disease \[[@ref1]--[@ref3]\], hypertension \[[@ref4], [@ref5]\], and cancers \[[@ref6]--[@ref8]\]. In addition, it has been demonstrated that vitamin D maintains normal glucose homeostasis \[[@ref9], [@ref10]\]. Vitamin D deficiency is reported to be associated with insulin resistance, high risk of pre-diabetes and type 2 diabetes mellitus (DM) \[[@ref11]\].

Both of vitamin D and parathyroid hormone (PTH) contribute to maintaining calcium (Ca) homeostasis \[[@ref12]\]. Vitamin D is associated with intestinal Ca absorption. Low serum Ca level promotes PTH secretion to stimulate the resorption of Ca from bone and the renal reabsorption of Ca \[[@ref12]\], which is defined as secondary hyperparathyroidism that could increase the risk of DM \[[@ref13], [@ref14]\].

Gestational diabetes mellitus (GDM) is a growing health problem. It is defined as glucose intolerance, which commonly occurs during pregnancy \[[@ref15]\]. Its relationship with adverse newborn and pregnancy outcomes is well known \[[@ref16]\]. Obesity and lifestyle are the main risk factors for GDM \[[@ref17], [@ref18]\]. Some studies have reported a significant relationship between 25(OH)D deficiency and GDM, while others did not find such an association \[[@ref19]--[@ref22]\]. The opinions about the relationship of GDM and 25(OH)D levels are inconsistent \[[@ref19]--[@ref22]\]. Previously published meta-analyses analyzed the relationship of 25(OH)D deficiency and GDM \[[@ref23]--[@ref25]\], but studies published in Chinese were not considered in these meta-analyses.

The present meta-analysis included articles in Chinese and the results seem to be much more accurate. Levels of vitamin D in GDM subjects and healthy ones were analyzed. Meanwhile, the relationship of vitamin D with risk of GDM was also investigated.

Material and methods {#S2}
====================

Search strategy {#S2_1}
---------------

The present meta-analysis was conducted according to the PRISMA statement about meta-analysis \[[@ref26]\]. Two researchers independently performed searches for the related articles (up to September 2019) in the PubMed and CNKI databases. Keywords included 1,25-dihydroxycholeclciferol or 25(OH)D or vitamin D or 25-hydroxy vitamin D and GDM or gestational diabetes mellitus. The obtained articles were scanned and the reference lists of all articles were checked manually. To decrease bias, two researchers performed the searches and any inconsistent opinions were resolved with a discussion.

Inclusion and exclusion criteria {#S2_2}
--------------------------------

The obtained articles were selected according to inclusion and exclusion criteria. During evaluation, abstracts and titles of obtained articles were screened carefully. Only studies that conducted analysis among pregnant woman without illness were considered. Meanwhile, papers that compared vitamin D level between women with GDM and women with normal glucose tolerance (NGT) would be selected. In addition, papers that reported an estimation of effect (odds ratio -- OR) to compare sufficient and insufficient vitamin D values were also selected. Studies based on non-human experiments, duplicate publications, reviews, meta-analysis, and those that provided insufficient data were excluded from the analysis.

Data extraction {#S2_3}
---------------

The following data were extracted from included studies: name of first author, year of publication, sample size, gestational age, vitamin D levels and status among GDM and healthy subjects. For more information, the authors would be contacted for supplementary data. Disagreements were resolved via a discussion.

Data synthesis and statistical analysis {#S2_4}
---------------------------------------

STATA software was used for statistical analyses. OR with 95% confidence interval (CI) was applied to evaluate the relationship of vitamin D with the risk of GDM. Standard mean difference (SMD) along with 95% CI was used to compare vitamin D level between women with GDM and healthy subjects. Meanwhile, the correlation coefficient between vitamin D and the homeostasis model assessment-insulin resistance index (HOMA-IR) was analyzed as well. Heterogeneity was assessed with *Q* and *I*^2^ statistics. When heterogeneity was observed, a random-effects model was used in the analysis. Publication bias was tested by Egger's and Begg's analyses. All statistical tests were two sided.

Results {#S3}
=======

Selection process of articles {#S3_1}
-----------------------------

After the initial search, 248 potential articles were obtained. Eight additional articles were identified through manual search of the references. Overall, 256 potential articles were confirmed. After screening the abstracts and titles, 97 articles were removed. After a full-text review, 106 articles were excluded. Fifty-three studies were selected \[[@ref19], [@ref20], [@ref22], [@ref27]--[@ref76]\]. The selection process is shown in [Figure 1](#F1){ref-type="fig"}. Basic information of included articles is listed in [Table I](#T1){ref-type="table"}.

![Selection process of included articles. Fifty-three studies were included in the present meta-analysis](AMS-16-40359-g001){#F1}

###### 

Basic information of studies

  Author                          Year   Country          Subjects, *n*   Gestational diabetes, *n*   Diagnosis time \[weeks\]   Assay method                           Cut-off values \[nmol/l\]
  ------------------------------- ------ ---------------- --------------- --------------------------- -------------------------- -------------------------------------- ---------------------------
  Liu Y \[[@ref27]\]              2015   China            174             85                          24--28                     Electrochemiluminescence               --
  Wu YX \[[@ref28]\]              2016   China            240             120                         11                         ELISA                                  50
  Cai YQ \[[@ref29]\]             2017   China            400             200                         24--28                     ELISA                                  50
  Tao \[[@ref30]\]                2015   China            176             88                          24.28                      Electrochemiluminescence               --
  Zhou JL \[[@ref31]\]            2017   China            7000            1012                        24--28                     ELISA                                  --
  Ye \[[@ref32]\]                 2015   China            82              41                          24--28                     ELISA                                  50
  Zhang SF \[[@ref33]\]           2015   China            100             50                          24--28                     Electrochemiluminescence               --
  Liu T \[[@ref34]\]              2013   China            50              25                          24--28                     ELISA                                  --
  Hou \[[@ref35]\]                2016   China            70              30                          24--28                     ELISA                                  --
  Liang \[[@ref36]\]              2016   China            60              30                          24--28                     ELISA                                  25
  Wang YL \[[@ref37]\]            2016   China            100             50                          24--28                     Electrochemiluminescence               75
  Guan \[[@ref38]\]               2016   China            90              60                          24--28                     radioimmunoassay                       --
  Lei \[[@ref39]\]                2014   China            433             118                         24--28                     Electrochemiluminescence               75
  Zhang YJ \[[@ref40]\]           2017   China            400             200                         24--28                     ELISA                                  --
  Zhang CY \[[@ref41]\]           2013   China            372             124                         24--28                     CLIA                                   50
  Liu Y \[[@ref42]\]              2017   China            72              36                          24--28                     ELISA                                  75
  Song \[[@ref43]\]               2015   China            180             78                          24--28                     ELISA                                  75
  Hu \[[@ref44]\]                 2015   China            74              37                          28                         ELISA                                  50
  Lu \[[@ref45]\]                 2010   China            55              29                          24--30                     ELISA                                  --
  Zhu \[[@ref46]\]                2016   China            110             55                          24                         Electrochemiluminescence               --
  Cai F \[[@ref47]\]              2016   China            1305            133                         24--28                     ELISA                                  --
  Wang X \[[@ref48]\]             2016   China            243             123                         23--41                     ELISA                                  --
  Shen X \[[@ref49]\]             2015   China            200             100                         24--28                     CLIA                                   50
  Shen F \[[@ref50]\]             2013   China            528             36                          16--20                     ELISA                                  --
  Si \[[@ref51]\]                 2014   China            446             55                          17--21                     ELISA                                  --
  Bei \[[@ref52]\]                2014   China            100             50                          24--28                     LC--MS/MS                              --
  Yuan \[[@ref53]\]               2017   China            717             478                         24--28                     ELISA                                  --
  Zhou Y \[[@ref54]\]             2016   China            7773            977                         24--28                     --                                     --
  Zhang CL \[[@ref55]\]           2008   America          171             57                          24--28                     ELISA                                  75
  Parlea \[[@ref56]\]             2012   Canada           335             116                         24--28                     CLIA                                   --
  Wang \[[@ref58]\]               2012   China            400             200                         26--28                     ELISA                                  50
  Bener \[[@ref59]\]              2013   Qatar            1873            260                         24--28                     Radioimmunoassay                       75
  Parildar \[[@ref60]\]           2013   Turkey           122             44                          24--32                     CLIA                                   50
  Zuhur \[[@ref61]\]              2013   Turkey           402             234                         24--28                     Electrochemiluminescence               50
  Arnold \[[@ref62]\]             2015   America          652             135                         24--28                     LC--MS/MS                              75
  Dodds \[[@ref63]\]              2016   Canada           2320            395                         24--28                     CLIA                                   50
  Schneuer \[[@ref64]\]           2014   Australia        4090            376                         24.28                      CLIA                                   50
  Maghbooli \[[@ref19]\]          2008   Iran             579             52                          24--28                     Radioimmunoassay                       34.9
  Clifton-Bligh \[[@ref20]\]      2008   Australia        264             81                          28.7                       Nichols Advantage assay                --
  Soheilykhah \[[@ref65]\]        2015   Iran             54              165                         24--28                     ELISA                                  75
  Makgoba \[[@ref22]\]            2011   UK               248             90                          24--28                     LC--MS/MS                              --
  Savvidou \[[@ref66]\]           2011   UK               1100            100                         24--28                     LC--MS/MS                              --
  Baker \[[@ref67]\]              2012   America          180             60                          24--28                     LC--MS/MS                              75
  Burris \[[@ref68]\]             2012   America          1246            68                          26--28                     CLIA                                   75
  Fernandez-Alonso \[[@ref69]\]   2012   Spain            466             36                          24--28                     Electrochemiluminescence immunoassay   75
  Lacroix \[[@ref70]\]            2014   Canada           655             54                          24--28                     Immunoassay system                     75
  Park \[[@ref71]\]               2014   Korea            523             23                          24--28                     Electrochemiluminescence immunoassay   50
  Boyle \[[@ref72]\]              2016   UK               1544            32                          24--28                     LC--MS/MS                              75
  Hauta-Alus \[[@ref75]\]         2017   Finland          723             81                          24--28                     CLIA                                   80
  Shen \[[@ref76]\]               2011   China            1030            52                          24.28                      ELISA                                  50
  Yang \[[@ref57]\]               2013   China            70              35                          24--28                     ELISA                                  50
  Loy \[[@ref73]\]                2015   Singapore        940             155                         26--28                     LC--MS/MS                              75
  Pleskacova \[[@ref74]\]         2015   Czech Republic   76              47                          24--30                     ELISA                                  50

LC-MS/MS -- liquid chromatography-tandem mass spectroscopy, CLIA -- chemiluminescence immunoassay.

Comparison in vitamin D level between women with GDM and healthy subjects {#S3_2}
-------------------------------------------------------------------------

A total of 43 articles with a population of 28,827 compared the vitamin D level between women with GDM and healthy subjects ([Figure 2](#F2){ref-type="fig"}). During analysis, the SMD statistic was applied due to inconsistent units. In the analysis, we found that vitamin D level of GDM subjects was much lower than that of healthy subjects (SMD = --0.71, 95% CI: --0.91, --0.50).

![Comparison of vitamin D level between women with GDM and healthy subjects. Vitamin D level of GDM subjects was much lower than that of healthy subjects (SMD = --0.71, 95% CI: --0.91, --0.50). The horizontal line indicates the lower and upper limits of the 95% CI; the square indicates the SMD, with the size of the square indicating the weight of the study and the dotted red line indicating the combined SMD value. The diamond represents the combined effect size, and the larger the diamond, the larger the confidence interval. A cross between the diamond and the ineffective line indicates no statistical difference between GDM and healthy subjects in vitamin D level; if the diamond falls on the left side of the invalid line, it indicates a lower level of vitamin D among GDM subjects, compared to that of healthy subjects; if the diamond falls on the right side of the line, it indicates a higher level of vitamin D among GDM subjects, compared to that of healthy subjects\
*SMD -- standard mean difference, CI -- confidence interval*.](AMS-16-40359-g002){#F2}

Relationship of vitamin D with GDM risk {#S3_3}
---------------------------------------

Altogether 21 articles with a population of 16,177 reported a relationship of vitamin D and risk of GDM ([Figure 3](#F3){ref-type="fig"}). Two studies reported a significant relationship, and 19 studies reported no significant relationship. Due to significant heterogeneity (*p* \< 0.001), the meta-analysis was performed with a random-effects model. It showed that vitamin D deficiency was associated with high risk of GDM (OR = 1.15, 95% CI: 1.07--1.23).

![Relationship of vitamin D with GDM risk. Vitamin D deficiency was closely associated with high risk of GDM (OR = 1.15, 95% CI: 1.07--1.23). The horizontal line indicates the lower and upper limits of the 95% CI; the square indicates the OR, with the size of the square indicating the weight of the study and the dotted red line indicating the combined SMD value. The diamond represents the combined effect size, and the larger the diamond, the larger the confidence interval. A cross between the diamond and the ineffective line indicates no statistical correlation between the factors studied and the outcome; if the diamond falls on the left side of the invalid line, it indicates a protective factor; if the diamond falls on the right side of the line, it indicates a risk factor\
*OR -- odds ratio, CI -- confidence interval*.](AMS-16-40359-g003){#F3}

Correlation coefficient between vitamin D and HOMA-IR {#S3_4}
-----------------------------------------------------

A total of 8 articles with a population of 2,376 analyzed the correlation coefficient between vitamin D level and HOMA IR ([Figure 4](#F4){ref-type="fig"}). The outcome indicated that vitamin D was negatively correlated with HOMA-IR (*r* = --0.62, 95% CI: --0.85, --0.39).

![Analysis of the correlation coefficient between vitamin D level and HOMA-IR. Vitamin D was negatively correlated with HOMA-IR (*r* = --0.62, 95% CI: --0.85, --0.39). The horizontal line indicates the lower and upper limits of the 95%CI; the square indicates the effective size with the size of the square indicating the weight of the study and the dotted red line indicating the combined effective size value. The diamond represents the combined effect size, and the larger the diamond, the larger the confidence interval. A cross between the diamond and the ineffective line indicates the correlation coefficient between vitamin D level and HOMA-IR; if the diamond falls on the left side of the invalid line, it indicates a negative correlation; if the diamond falls on the right side of the line, it indicates a positive correlation\
*ES -- effective size, CI -- confidence interval*.](AMS-16-40359-g004){#F4}

Sensitivity analysis {#S3_5}
--------------------

Sensitivity analysis was performed. Each study was sequentially removed and the overall results did not change, which indicated that the results were robust.

Publication bias {#S3_6}
----------------

Potential publication bias was detected via funnel plot ([Figure 5](#F5){ref-type="fig"}). Egger's and Begg's tests showed no publication bias (Egger's: *p* = 0.197; Begg's: *p* = 0.786).

![Begg's funnel plot. Egger's and Begg's tests showed no publication bias (Egger's: *p* = 0.197; Begg's: *p* = 0.786)](AMS-16-40359-g005){#F5}

Discussion {#S4}
==========

The pathogenesis of disease involves many factors, such as genes, infections, environment and nutrition supplementation \[[@ref77]--[@ref85]\], which regulates the metabolism of some molecules, thus resulting in the diseases \[[@ref86], [@ref87]\]. GDM is a well-known complication with high prevalence during pregnancy. It shows an imbalance between insulin secretion and insulin resistance, resulting in maternal hyperglycemia \[[@ref88]\]. The risk factors for GDM include maternal age, obesity prior to and during pregnancy, family history of diabetes and previous history of GDM \[[@ref89]\]. However, these factors cannot serve as predictors of GDM development in half of all cases \[[@ref90]\]. Lower 25(OH)D concentrations have been demonstrated to be associated with insulin resistance, maternal glycemia, and high risk of GDM. However, the relationship of 25(OH)D with risk of GDM has not been well defined. The present meta-analysis was performed to reach a definite conclusion on this topic.

Some studies suggested a relationship of 25(OH)D with increased risk of GDM \[[@ref20], [@ref21], [@ref55], [@ref65], [@ref91]\]. A recent study did not find evidence for the relationship of 25(OH)D with GDM \[[@ref22]\]. Another study reported a similar result, but it suggested an inverse relationship of glucose concentrations with 25(OH)D level 30 min after a 100 g glucose load \[[@ref21]\]. Physical activity is an important confounder of the relationship of 25(OH)D and GDM. Thanks to sunlight exposure, active women have less risk of developing impaired glucose tolerance and seem to have higher 25(OH)D levels than less active women \[[@ref92], [@ref93]\].

In the analysis, a total of 43 articles compared the vitamin D level between GDM and healthy subjects. The overall outcome revealed that the vitamin D level of women with GDM was much lower than that of healthy subjects. Altogether 21 articles reported a relationship of vitamin D status and risk of GDM. Two articles reported a significant relationship and 19 articles reported no significant relationship. The outcome showed that vitamin D deficiency was significantly correlated with increased risk of GDM. Meanwhile, 8 articles analyzed the correlation coefficient between vitamin D and HOMA IR. We found that vitamin D was negatively correlated with HOMA-IR, which contributes to revealing the relationship of vitamin D and GDM. It is common to compare the clinical efficacy of methods for disease \[[@ref94]--[@ref96]\]. There were articles reporting the beneficial effects of vitamin D supplementation on the GDM \[[@ref97]--[@ref100]\]. Zhang *et al*. reported that high-dose vitamin D supplementation significantly improved insulin resistance in pregnant women with GDM \[[@ref97]\]. Yazdchi *et al*. concluded that vitamin D supplementation improved FG and HbA~1c~ in GDM patients \[[@ref98]\]. The study by Shahgheibi *et al*. indicated that vitamin D supplementation in the first and second trimesters of pregnancy was effective in reducing GDM and controlling GTT and GTC \[[@ref99]\]. Another study by Mahdieh *et al*. indicated that 50,000 IU vitamin D every 2 weeks decreased the incidence of GDM \[[@ref100]\]. All these results were consistent with our outcomes.

The meta-analysis included 53 eligible articles, of which 30 articles were published in Chinese. The results seem to much more accurate; however, the analysis still has some limitations. First, the diagnostic time of GDM, detection method for 25(OH)D, and the cut-off value of vitamin D differed among these studies. Second, the impact of some important factors may affect the relationship of vitamin D deficiency and GDM; however, some studies did not adjust the results for confounding factors. Further randomized controlled trials are necessary to assess this relationship and explore the effects of vitamin D supplementation on the prevention of GDM.

In conclusion, the vitamin D level of women with GDM is much lower than that of healthy subjects. Vitamin D deficiency is significantly correlated with increased risk of GDM. Vitamin D is negatively correlated with HOMA-IR. The conclusion indicates that vitamin D is valuable for pregnant women. Detection of serum vitamin D should be performed on pregnant women, which helps in preventing GDM.
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